Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Active not recruiting 4Recruiting 3Completed 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Nasopharyngeal Carcinoma 20Squamous Cell Carcinoma of Head and Neck 7Oropharyngeal Neoplasms 7Prostatic Neoplasms 5Carcinoma 4Rectal Neoplasms 3Nasopharyngeal Neoplasms 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Stomatitis 2Pancreatic Adenocarcinoma 2Neoplasm Metastasis 2Meningeal Carcinomatosis 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Tumor Virus Infections 1Thyroid Carcinoma, Anaplastic 1Stomatognathic Diseases 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sarcoma 1Recurrence 1

Interventions

Magnetic Resonance Spectroscopy 9Specimen Handling 8Cisplatin 7pembrolizumab 4Radiation 4Platinum 4Biopsy 41,2-diaminocyclohexaneplatinum II citrate 4Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Cetuximab 3toripalimab 2cemiplimab 2Interviews as Topic 2Docetaxel 2Chemoradiotherapy 2Carboplatin 2sacituzumab govitecan 1merphos 1ipatasertib 1cobimetinib 1cabozantinib 1X-Rays 1Vemurafenib 1Tretinoin 1Transurethral Resection of Bladder 1Taxes 1Surveys and Questionnaires 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Laryngeal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT02734537 2026-05-15

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Eastern Cooperative Oncology Group

Phase 2 Recruiting
189 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT06532279 2026-05-04

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NRG Oncology

Phase 2 Recruiting
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT06914999 2025-10-22

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Emory University

Phase EARLY_PHASE1 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡